Medication-related problems in the Neonatal Intensive Care Unit (NICU)
DOI:
https://doi.org/10.33448/rsd-v13i12.47861Keywords:
Pharmaceutical Assistance; Metabolism; Pharmaceutical Preparations; Newborn; Pharmacological Treatment; Neonatal Intensive Care Units.Abstract
Introduction: Pharmacotherapy in neonates is challenging due to the immaturity of the organs responsible for the absorption, metabolism and excretion of medications. Objective: The objective of the present study is to carry out an integrative review of the literature on the main problems related to medications in neonatal intensive care units and the importance of pharmaceutical assistance to correct, minimize and prevent the occurrence of DRPs in NICUs. Method: A bibliographic survey was done in Google Scholar, Scientific Electronic Library Online (Scielo), Latin American and Caribbean Literature in Health Sciences (LILACS), and PubMed databases. Results: The main DRPs identified were prescription and administration errors linked to the lack of protocols and infrastructure. Premature neonates use medications with different specialties, many of these medications are classified as Off-Label (OL) and Unlicensed (UL). The Pharmaceutical Recommendations (RFs) were mainly related to dose adjustment, interval, and standard concentration. The RFs carried out had a good percentage of acceptance by the multidisciplinary team. Conclusion: The study showed that DRPs are very common in patients admitted to the NICU, and reinforces the importance of the pharmacist to correct, minimize, and prevent these errors from happening, ensuring the safety and effectiveness of pharmacotherapy in NBs.
References
Anima. (2014). Manual revisão bibliográfica sistemática integrativa: a pesquisa baseada em evidências. Grupo Anima.
Azevedo, L. L. & Costa, R. S. (2022). Problemas relacionados ao uso de medicamentos administrados via sonda nasoenteral em pacientes neonatais. Conjecturas. 22(5), 640-57.
Bartelink, I. H. et al. (2006). Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clinical Pharmacokinetics. 45(11), 1077-97.
Becker, G. C., Machado, F. R. & Bueno, D. (2016). Perfil de utilização de medicamentos em pacientes pediátricos em cuidados intensivos. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 7(2), 2016.
Bittencourt, S. C., Caponi, S. & Maluf, S. (2013). Farmacologia no século XX: a ciência dos medicamentos a partir da análise do livro de Goodman e Gilman. História, Ciências, Saúde-Manguinhos. 20(2), 499-520.
Brasil. (2012). Portaria GM/MS nº 930, de 10 de maio de 2012 do Ministério da Saúde.
Carneiro, A. I. C. & Silva, A. H. (2018). Segurança do paciente em unidade de terapia intensiva neonatal: o impacto das recomendações farmacêuticas. Conexão Fametro, 2018.
Carvalho, T. R. et al. (2021). Análise de interações medicamentosas potenciais na UTI neonatal de um hospital público da Bahia. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 1(2), 628.
Chua, S. S., Chua, H. M. & Omar, A. (2010). Drug administration errors in paediatric wards: a direct observation approach. European Journal of Pediatrics. 169, 603-11. https://doi.org/10.1007/s00431-009-1084-z.
Coelho, H. L. L. (2013). A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename). Journal of Pediatrics. 8(2), 171-8.
Crossetti, M. G. M. (2012). Revisión integradora de la investigación en enfermería el rigor científico que se le exige. Rev. Gaúcha Enferm. 33(2): 8-9.
Cuzzolin, L. & Agostino, R. (2016). Off-label and unlicensed drug treatments in neonatal intensive care units: an Italian multicentre study. European Journal of Clinical Pharmacology. 72(1), 117-23.
Dessì, A. et al. (2010). Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci. 32(2), 120-4.
DRUGDEX System. (2010). Thomson Micromedex. Healthcare Series 20: interactions. Greenwood Village, CO, 2010.
Evangelista, B. P. et al. (2022). Segurança do paciente pediátrico no uso de medicamentos na Unidade de Terapia Intensiva. Research, Society and Development. 11(8), e28911831225-e28911831225.
Fabretti, S. de C. et al. (2018). Rastreadores para a busca ativa de eventos adversos a medicamentos em recém-nascidos. Cadernos de Saúde Pública. 34(9), e00069817.
Ferreira, A. M. D. et al. (2019). Percepções dos profissionais de enfermagem acerca do uso da informatização para segurança do paciente. Revista Gaúcha de Enfermagem. 40. DOI: 10.1590/1983-1447.2019.20180140.
Ferreira, T. S. et al. (2023). Morte precoce, morbidade e farmacoterapia em prematuros extremos e muito prematuros em unidades de terapia intensiva neonatal. Revista Brasileira de Saúde Materno Infantil. 23, e20210288.
Frattarelli, D. A. et al. (2014). American Academy of Pediatrics Committee on Drugs. Offlabel use of drugs in children. Pediatrics. 133(3), 563-7.
Garner, S. S. et al. (2015). Prospective, controlled study of an intervention to reduce errors in neonatal antibiotic orders. Journal of Perinatology. 35(8), 631-5.
Gomes, V. P. et al. (2015). Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital. Farmácia Hospitalar. 39(3), 176-80.
Goodman, L. S. & Gilman, A. (1975). Preface to the fifth edition. In: Goodman, Louis S. et al. (Ed.). The pharmacological basis of therapeutics: a textbook of pharmacology, toxicology and therapeutics for physicians and medical students. (5.ed.). New York: Macmillan. p.V-VI. 1975.
Khasawneh, W. & Khriesat, W. (2020). Assessment and comparison of mortality and short-term outcomes among premature infants before and after 32-week gestation: a cross-sectional analysis. Annals of Medicine and Surgery (Lond). 60, 44-9.
Lima, E. C. et al. (2020). Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit. Frontiers in Pharmacology. 11. DOI: https://doi.org/10.3389/fphar.2020.555407.
Locatelli, J., Mancio, C. M. & Globo, N. T. (2014). Atuação do Farmacêutico em Unidade de Terapia Intensiva. Editora Atheneu.
Mattos, P. C. (2015). Tipos de revisão de literatura. Unesp, 1-9. Recuperado de https://www.fca.unesp.br/Home/Biblioteca/tipos-de-evisao-de-literatura.pdf.
MCintyre, J. et al. (2000). Unlicensed and off label prescribing of drugs in general practice. Archives of Disease in Childhood. 83(6), 498-501.
Nascimento, A. R. F. et al. (2020). Problemas relacionados a medicamentos em neonatos cardiopatas sob terapia intensiva. Revista Paulista de Pediatria. 38, e201813.
Nunes, B. Me., Xavier, T. C. & Martins, R. R. (2017). Problemas relacionados a medicamentos antimicrobianos em unidade de terapia intensiva neonatal. Revista Brasileira de Terapia Intensiva. 29, 331-6.
Oliveira, C. R. V. et al. (2021). Utilização de antimicrobianos em uma Unidade de Terapia Intensiva Neonatal: um estudo transversal retrospectivo. Research, Society and Development. 10(1), e29810111794-e29810111794.
Oliveira, E. K. F., Zangalli, K. R. & Tavares, S. S. (2022). Eventos adversos no processo de medicação em unidade de terapia intensiva neonatal: uma revisão integrativa da literatura. Revista Saúde em Foco. (14), 1277-93.
Oliveira, L. P. D. et al. (2022). Indicadores clínicos da farmácia clínica em unidades de terapia intensiva neonatais: Farmácia clínica. Neonatología. Indicadores. Research, Society and Development. 11(5), e23211526061-e23211526061.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Editora UAB/NTE/UFSM.
Pharmaceutical Care Network Europe (2010). Classification for drug related problems. V 6.2 [Internet]. 2010.
http://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf.
Queiroz, K. C. B. et al. (2014). Análise de Interações Medicamentosas Identificadas em Prescrições da UTI Neonatal da ICU-HGU. Journal of Health Sciences. 16(3). DOI: 10.17921/2447-8938.2014v16n3p%p. https://journalhealthscience.pgsscogna.com.br/JHealthSci/article/view/443.
Rang, R. et al. (2011). Rang & Dale: Farmacologia. (7. ed.). Elsevier.
Rodieux, F. et al. (2015). Effect of kidney function on drug kinetics and dosing in neonates, infants, and children. Clinical Pharmacokinetics. 54, 1183-204. https://doi.org/10.1007/s40262-
Santos, J. S. et al. (2023). Estudo da utilização de medicamentos em neonatos da unidade de terapia intensiva em maternidade de referência. Research, Society and Development. 12(1), e23912139640-e23912139640.
Santos, L. (2009). Medicamentos potencialmente perigosos, não aprovados e de uso off label em prescrições pediátricas de um hospital universitário [dissertação]. Porto Alegre: Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul.
Shirkey, H. (1999). Therapeutic Orphans. Pediatrics. 104(3), 583-4.
Sorrentino, E. & Alegiani, C. (2012). Medication errors in the neonate. Journal of Maternal-Fetal & Neonatal Medicine. 25(Suppl. 4), 91-3.
https://doi.org/10.3109/14767058.2012.714994.
Toaldo, F. et al. (2024). Perfil do uso de medicamentos off-label e não-licenciados em uma Unidade de Terapia Intensiva neonatal. Research, Society and Development. 1 (7), e8813745643-e8813745643.
Vieira, V. C. et al. (2021). Prescrição de medicamentos off-label e sem licença para prematuros de unidade de terapia intensiva neonatal. Revista Brasileira de Terapia Intensiva. 33(2), 266-75.
Wilbaux, M. et al. (2016). Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates. Journal of Clinical Pharmacology. 56, 909-35. https://doi.org/10.1002/jcph.705.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gabriela Martines Almeida Oliveira; Ane Beatriz Dantas Celestino; Basma Mohamed Ahmed Hassan; Raquel Silveira Bertoluci
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
